. Each of the Loan Parties has # good, sufficient and legal title to (in the case of fee interests in Real Property), # valid leasehold interests in (in the case of leasehold interests in real or personal property), and # good and marketable title to (in the case of all other personal property), all of their respective assets reflected in their most recent financial statements delivered pursuant to Section 5.1, in each case

Title; Encumbrances. (i) It solely owns the [[Aravive:Organization]] Licensed Patents or otherwise has sufficient legal and/or beneficial title or ownership or license with respect to the [[Aravive:Organization]] Technology, as necessary to grant the licenses to [[3D Medicines:Organization]] as purported to be granted pursuant to this Agreement, free and clear from any mortgages, pledges, liens, security interests, conditional and installment sale agreement, encumbrances, charges or claim of any kind, and # to [[Aravive:Organization]]’s knowledge, no Third Party has taken any action before the United States Patent and Trademark Office, or any counterpart thereof outside the U.S., claiming legal and/or beneficial title or ownership or license of any [[Aravive:Organization]] Technology;

Title; Encumbrances. Except for the Information licensed to FibroGen under the Astellas Agreements, FibroGen Cayman is the sole and exclusive owner of the entire right, title and interest in # the Listed Patents and # the FibroGen China Know-How existing as of the Effective Date. Neither the Listed Patents nor the FibroGen China Know-How owned by FibroGen Cayman is subject to any mortgage, pledge, lien, security interest, conditional and installment sale agreement, encumbrance or charge or claim of any kind.

Title; Encumbrances. Except for the Xenon Know-How that is licensed to Xenon pursuant to the Genentech License and the Xenon Know-How and Xenon Patent Rights that are licensed to Genentech pursuant to the Genentech License, Xenon is the sole owner of the entire right, title and interest in and to all Xenon Licensed IP existing as of the Effective Date, free and clear from any mortgages, pledges, liens, security interests, conditional and installment sale agreements, encumbrances, charges or claims of any kind. Xenon has the full and legal rights and authority to license to Neurocrine the Xenon Licensed IP as set forth herein.

Title; Encumbrances. [* * *] to grant the licenses to the other Party as purported to be granted pursuant to this Agreement;

Title; Encumbrances. (i) It has sufficient legal and/or beneficial title or ownership or license, free and clear from any mortgages, pledges, liens, security interests, conditional and installment sale agreement, encumbrances, charges or claim of any kind, of the [[GlycoMimetics:Organization]] Technology to grant the licenses to Apollomics as purported to be granted pursuant to this Agreement; and # to [[GlycoMimetics:Organization]]’ knowledge, no Third Party has taken any action before the United States Patent and Trademark Office, or any counterpart thereof outside the U.S., claiming legal and/or beneficial title or ownership or license of any [[GlycoMimetics:Organization]] Technology;

Title and Encumbrances. Each of the Borrowers has good and marketable title to its interest in the Properties and there are no Liens on any of the Properties other than Permitted Encumbrances.

Title; Encumbrances. [* * *] to grant the licenses to the other Party as purported to be granted pursuant to this Agreement;

Subsequent Title Encumbrances. Notwithstanding the provisions of Section 5(c) above, any encumbrances or defects that first arise after the date and time of Purchaser’s title commitment and which affect the applicable Property (“Subsequent Title Encumbrances”) shall not be deemed Permitted Encumbrances, provided Purchaser notifies Seller

Title; Encumbrances. Lytix is the sole owner of the entire right, title and interest in and to all Patents and other intellectual property rights within the Licensed Technology, free and clear from any mortgages, pledges, liens, security interests, conditional and installment sale agreements, encumbrances, charges or claims of any kind. Lytix has the full and legal rights and authority to grant all rights and licenses it purports to grant to Verrica under this Agreement;